EUVIMEDEUVIMED entdecken
Open Access

Exosomes derived from BMSCs ameliorate cyclophosphamide-induced testosterone deficiency by enhancing the autophagy of Leydig cells via the AMPK-mTOR signaling pathway

Hao-Yu Liang, Fan Peng, Min-Jia Pan, Sen-Lin Liao, Cun Wei, Guan-Yang Wei, Xiao Xie, Kang-Yi Xue, Ming-Kun Chen, Jian-Kun Yang, Wen-Bin Guo, Cun-Dong Liu und 1 weitere

Asian Journal of Andrology · 2023-07 · 25 (4) · 474-483

DOI: 10.4103/aja202286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Journal of Andrology, online erschienen am 13.12.2022. Verfasst von Hao-Yu Liang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630; The Third School of Clinical Medicine, Souther…. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Exosomes. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclophosphamide-induced testosterone deficiency (CPTD) during the treatment of cancers and autoimmune disorders severely influences the quality of life of patients. Currently, several guidelines recommend patients suffering from CPTD receive testosterone replacement therapy (TRT). However, TRT has many disadvantages underscoring the requirement for alternative, nontoxic treatment strategies. We previously reported bone marrow mesenchymal stem cells-derived exosomes (BMSCs-exos) could alleviate cyclophosphamide (CP)-induced spermatogenesis dysfunction, highlighting their role in the treatment of male reproductive disorders. Therefore, we further investigated whether BMSCs-exos affect autophagy and testosterone synthesis in Leydig cells (LCs). Here, we examined the effects and probed the molecular mechanisms of BMSCs-exos on CPTD in vivo and in vitro by detecting the expression levels of genes and proteins related to autophagy and testosterone synthesis. Furthermore, the testosterone concentration in serum and cell-conditioned medium, and the photophosphorylation protein levels of adenosine monophosphate-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) were measured. Our results suggest that BMSCs-exos could be absorbed by LCs through the blood–testis barrier in mice, promoting autophagy in LCs and improving the CP-induced low serum testosterone levels. BMSCs-exos inhibited cell death in CP-exposed LCs, regulated the AMPK-mTOR signaling pathway to promote autophagy in LCs, and then improved the low testosterone synthesis ability of CP-induced LCs. Moreover, the autophagy inhibitor, 3-methyladenine (3-MA), significantly reversed the therapeutic effects of BMSCs-exos. These findings suggest that BMSCs-exos promote LC autophagy by regulating the AMPK-mTOR signaling pathway, thereby ameliorating CPTD. This study provides novel evidence for the clinical improvement of CPTD using BMSCs-exos.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesExosomesMiceMaleAnimalsLeydig CellsQuality of LifeSignal TransductionTOR Serine-Threonine KinasesAutophagyTestosteroneMammals

Stichwörter der Autor:innen

Leydig cellsautophagybone marrow mesenchymal stem cellscyclophosphamideexosomestestosterone deficiency

Substanzen

AMP-Activated Protein KinasesTOR Serine-Threonine KinasesTestosterone

Autor:innen und Institutionen

  • Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630; The Third School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China.
  • The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China.

Zitieren

APA

Liang, H. Y., Peng, F., Pan, M. J., Liao, S. L., Wei, C., Wei, G. Y., Xie, X., Xue, K. Y., Chen, M. K., Yang, J. K., Guo, W. B., Liu, C. D., & Zhou, Q. Z. (2023). Exosomes derived from BMSCs ameliorate cyclophosphamide-induced testosterone deficiency by enhancing the autophagy of Leydig cells via the AMPK-mTOR signaling pathway. Asian Journal of Andrology, 25(4), 474-483. https://doi.org/10.4103/aja202286

Vancouver

Liang HY, Peng F, Pan MJ, Liao SL, Wei C, Wei GY, et al. Exosomes derived from BMSCs ameliorate cyclophosphamide-induced testosterone deficiency by enhancing the autophagy of Leydig cells via the AMPK-mTOR signaling pathway. Asian Journal of Andrology. 2023;25(4):474-483. doi:10.4103/aja202286

BibTeX
@article{Liang2023,
  author = {Liang, Hao-Yu and Peng, Fan and Pan, Min-Jia and Liao, Sen-Lin and Wei, Cun and Wei, Guan-Yang and Xie, Xiao and Xue, Kang-Yi and Chen, Ming-Kun and Yang, Jian-Kun and Guo, Wen-Bin and Liu, Cun-Dong and Zhou, Qi-Zhao},
  title = {Exosomes derived from BMSCs ameliorate cyclophosphamide-induced testosterone deficiency by enhancing the autophagy of Leydig cells via the AMPK-mTOR signaling pathway},
  journal = {Asian Journal of Andrology},
  year = {2023},
  volume = {25},
  number = {4},
  pages = {474--483},
  doi = {10.4103/aja202286}
}
Kostenlos starten →